
Sign up to save your podcasts
Or


Vidcast: https://youtu.be/zovNdjPYI2w
The FDA and Amneal Pharmaceuticals announce the recall of its Gemini Laboratories Nizatidine oral solution, 15 mg/ml. This product has potentially toxic levels of N-nitrosodimethylamine (NDMA). This agent is a probable human carcinogen. Three lots have been recalled: 06598004A, 06599001A, and 06599002A. This is a prescription product. If you have this product, return it to the pharmacy. Speak with your doctor about an alternative medication. For more information, call the company at 1-855-319-4807.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-nizatidine-oral-solution-15-mgml-due
#recall #nizatidine #ndma
By Howard G. Smith MD, AM
Vidcast: https://youtu.be/zovNdjPYI2w
The FDA and Amneal Pharmaceuticals announce the recall of its Gemini Laboratories Nizatidine oral solution, 15 mg/ml. This product has potentially toxic levels of N-nitrosodimethylamine (NDMA). This agent is a probable human carcinogen. Three lots have been recalled: 06598004A, 06599001A, and 06599002A. This is a prescription product. If you have this product, return it to the pharmacy. Speak with your doctor about an alternative medication. For more information, call the company at 1-855-319-4807.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-nizatidine-oral-solution-15-mgml-due
#recall #nizatidine #ndma